Le Transmettre P/E de Polar Capital Global Healthcare Trust Plc est N/A
Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Polar Capital Global Healthcare Trust plc is a closed ended equity mutual fund launched and managed by Polar Capital LLP. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on companies involved in pharmaceuticals, medical services, medical devices, and biotechnology. The fund primarily invests in dividend paying growth stocks of large-cap companies having a market capitalization greater than US $5 billion. It employs fundamental analysis with a bottom up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI ACWI/Health Care Index. It was formerly known as Polar Capital Global Healthcare Growth and Income Trust plc. Polar Capital Global Healthcare Trust plc was formed on May 12, 2010 and is domiciled in the United Kingdom.